---
stable_id: R-HSA-9013157
display_name: CDC42 binds effectors at the plasma membrane
species: Homo sapiens
summary: 'In its GTP bound active form, plasma membrane associated CDC42 binds to
  the following effectors:<br>BAIAP2 (Krugmann et al. 2001; Kast et al. 2014)<br>CDC42BPA
  (also known as MRCK alpha or MRCKA) (Leung et al. 1998; Schwarz et al. 2012; Bagci
  et al. 2020)<br>CDC42BPB (also known as MRCK beta or MRCKB) (Zihni et al. 2017;
  Bagci et al. 2020)<br>CDC42EP1 (also known as Borg5) (Joberty et al. 1999; Bagci
  et al. 2020)<br>CDC42EP2 (also known as Borg1) (Joberty et al. 1999; Bagci et al.
  2020)<br>CDC42EP3 (also known as Borg2) (Joberty et al. 1999)<br>CDC42EP4 (also
  known as Borg4) (Joberty et al. 1999; Bagci et al. 2020)<br>CDC42EP5 (also known
  as Borg3) (Joberty et al. 1999)<br>FMNL1 (Kuhn et al. 2015)<br>FMNL2 (Block et al.
  2012; Kuhn et al. 2015)<br>FMNL3 (Richards et al. 2015)<br>FNBP1 (also known as
  FBP17) (Chan Wah Hak et al. 2018; Bagci et al. 2020)<br>FNBP1L (also known as Toca-1)  (Ho
  et al. 2004; Bagci et al. 2020)<br>IQGAP1 (Hart et al. 1996; Kuroda et al. 1996;
  Swart Mataraza et al. 2002)<br>IQGAP2 (Brill et al. 1996)<br>MAP3K11 (Leung and
  Lassam 1998)<br>PAK1 (Parrini et al. 2002; Bagci et al. 2020)<br>PAK2 (Wu and Wang
  2003; Bagci et al. 2020)<br>PAK3 (Rousseau et al. 2003)<br>PAK5 (Dan et al. 2002;
  Ching et al. 2003, Wu and Frost 2006)<br>PAK6 (Lee et al. 2002, Morse et al. 2016)<br>PAK7
  (Amado Azevedo et al. 2017)<br>PARD6A (Qiu et al. 2000)<br>PLD1 (Hammond et al.
  1997)<br>WASP complex, through interaction with WASP complex components WASL (Kim
  et al. 2000; Bagci et al. 2020), WAS (WASP) (Aspenstrom et al. 1996), WIPF1 (also
  known as WIP) (Ramesh et al. 1997), WIPF2 (Bagci et al. 2020) and WIPF3 (Bagci et
  al. 2020)<br><br>The following putative CDC42 effectors are annotated as candidates
  either because of the opposing findings reported by different studies or because
  they have only been reported in the high throughput screen by Bagci et al. 2020
  as proteins that bind to constitutively active CDC42 mutant:<br>ARFGAP2 (Bagci et
  al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARHGAP1 (Bagci et al. 2020)<br>ARHGEF7
  (Bagci et al. 2020)<br>CAV1 (Bagci et al. 2020)<br>CDC42SE2 (Bagci et al. 2020)<br>CPNE8
  (Bagci et al. 2020)<br>DAAM1 (Aspenstrom et al. 2006: binding to active CDC42; Higashi
  et al. 2008: no binding to active CDC42)<br>DEPDC1B (Bagci et al. 2020)<br>DIAPH3
  (Bagci et al. 2020)<br>GIT1 (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>GOLGA8R
  (Bagci et al. 2020)<br>IQGAP3 (Wang et al. 2007: binding to active CDC42; Bagci
  et al. 2020: no binding to active CDC42)<br>JUP (Bagci et al. 2020)<br>KCTD3 (Bagci
  et al. 2020)<br>LAMTOR1 (Bagci et al. 2020)<br>PAK4 (Bagci et al. 2020)<br>RAB7A
  (Bagci et al. 2020)<br>SCRIB (Bagci et al. 2020)<br>SH3PXD2A (Bagci et al. 2020)<br>SHKBP1
  (Bagci et al. 2020)<br>SNAP23 (Bagci et al. 2020)<br>STEAP3 (Bagci et al. 2020)<br>STOM
  (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3
  (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br>WDR81 (Bagci et al. 2020)<br>WDR91
  (Bagci et al. 2020)<br><br>CDC42 does not bind the following RHO GTPase effectors:<br>ARL13B
  (Bagci et al. 2020)<br>DIAPH1 (Higashi et al. 2008)<br>GFOD1 (Bagci et al. 2020)<br>GJA1
  (Bagci et al. 2020)<br>KIAA0355 (Bagci et al. 2020)<br>MPP7 (Bagci et al. 2020)<br>NIPSNAP2
  (Bagci et al. 2020)<br>PLEKHG3 (Bagci et al. 2020)<br>ROCK1 (Leung et al. 1996)<br>ROCK2
  (Leung et al. 1996)<br>RTKN (Reid et al. 1996)<br>SLC1A5 (Bagci et al. 2020)<br>SLC4A7
  (Bagci et al. 2020)<br>SLK (Yamada et al. 2000)<br>WASF1 (Miki et al. 1998) – component
  of the WAVE1 complex<br>WWP2 (Bagci et al. 2020)'
---

# CDC42 binds effectors at the plasma membrane
**Reactome ID:** [R-HSA-9013157](https://reactome.org/content/detail/R-HSA-9013157)
**Species:** Homo sapiens

## Summary

In its GTP bound active form, plasma membrane associated CDC42 binds to the following effectors:<br>BAIAP2 (Krugmann et al. 2001; Kast et al. 2014)<br>CDC42BPA (also known as MRCK alpha or MRCKA) (Leung et al. 1998; Schwarz et al. 2012; Bagci et al. 2020)<br>CDC42BPB (also known as MRCK beta or MRCKB) (Zihni et al. 2017; Bagci et al. 2020)<br>CDC42EP1 (also known as Borg5) (Joberty et al. 1999; Bagci et al. 2020)<br>CDC42EP2 (also known as Borg1) (Joberty et al. 1999; Bagci et al. 2020)<br>CDC42EP3 (also known as Borg2) (Joberty et al. 1999)<br>CDC42EP4 (also known as Borg4) (Joberty et al. 1999; Bagci et al. 2020)<br>CDC42EP5 (also known as Borg3) (Joberty et al. 1999)<br>FMNL1 (Kuhn et al. 2015)<br>FMNL2 (Block et al. 2012; Kuhn et al. 2015)<br>FMNL3 (Richards et al. 2015)<br>FNBP1 (also known as FBP17) (Chan Wah Hak et al. 2018; Bagci et al. 2020)<br>FNBP1L (also known as Toca-1)  (Ho et al. 2004; Bagci et al. 2020)<br>IQGAP1 (Hart et al. 1996; Kuroda et al. 1996; Swart Mataraza et al. 2002)<br>IQGAP2 (Brill et al. 1996)<br>MAP3K11 (Leung and Lassam 1998)<br>PAK1 (Parrini et al. 2002; Bagci et al. 2020)<br>PAK2 (Wu and Wang 2003; Bagci et al. 2020)<br>PAK3 (Rousseau et al. 2003)<br>PAK5 (Dan et al. 2002; Ching et al. 2003, Wu and Frost 2006)<br>PAK6 (Lee et al. 2002, Morse et al. 2016)<br>PAK7 (Amado Azevedo et al. 2017)<br>PARD6A (Qiu et al. 2000)<br>PLD1 (Hammond et al. 1997)<br>WASP complex, through interaction with WASP complex components WASL (Kim et al. 2000; Bagci et al. 2020), WAS (WASP) (Aspenstrom et al. 1996), WIPF1 (also known as WIP) (Ramesh et al. 1997), WIPF2 (Bagci et al. 2020) and WIPF3 (Bagci et al. 2020)<br><br>The following putative CDC42 effectors are annotated as candidates either because of the opposing findings reported by different studies or because they have only been reported in the high throughput screen by Bagci et al. 2020 as proteins that bind to constitutively active CDC42 mutant:<br>ARFGAP2 (Bagci et al. 2020)<br>ARFGAP3 (Bagci et al. 2020)<br>ARHGAP1 (Bagci et al. 2020)<br>ARHGEF7 (Bagci et al. 2020)<br>CAV1 (Bagci et al. 2020)<br>CDC42SE2 (Bagci et al. 2020)<br>CPNE8 (Bagci et al. 2020)<br>DAAM1 (Aspenstrom et al. 2006: binding to active CDC42; Higashi et al. 2008: no binding to active CDC42)<br>DEPDC1B (Bagci et al. 2020)<br>DIAPH3 (Bagci et al. 2020)<br>GIT1 (Bagci et al. 2020)<br>GIT2 (Bagci et al. 2020)<br>GOLGA8R (Bagci et al. 2020)<br>IQGAP3 (Wang et al. 2007: binding to active CDC42; Bagci et al. 2020: no binding to active CDC42)<br>JUP (Bagci et al. 2020)<br>KCTD3 (Bagci et al. 2020)<br>LAMTOR1 (Bagci et al. 2020)<br>PAK4 (Bagci et al. 2020)<br>RAB7A (Bagci et al. 2020)<br>SCRIB (Bagci et al. 2020)<br>SH3PXD2A (Bagci et al. 2020)<br>SHKBP1 (Bagci et al. 2020)<br>SNAP23 (Bagci et al. 2020)<br>STEAP3 (Bagci et al. 2020)<br>STOM (Bagci et al. 2020)<br>TFRC (Bagci et al. 2020)<br>TMPO (Bagci et al. 2020)<br>VAMP3 (Bagci et al. 2020)<br>VANGL1 (Bagci et al. 2020)<br>WDR81 (Bagci et al. 2020)<br>WDR91 (Bagci et al. 2020)<br><br>CDC42 does not bind the following RHO GTPase effectors:<br>ARL13B (Bagci et al. 2020)<br>DIAPH1 (Higashi et al. 2008)<br>GFOD1 (Bagci et al. 2020)<br>GJA1 (Bagci et al. 2020)<br>KIAA0355 (Bagci et al. 2020)<br>MPP7 (Bagci et al. 2020)<br>NIPSNAP2 (Bagci et al. 2020)<br>PLEKHG3 (Bagci et al. 2020)<br>ROCK1 (Leung et al. 1996)<br>ROCK2 (Leung et al. 1996)<br>RTKN (Reid et al. 1996)<br>SLC1A5 (Bagci et al. 2020)<br>SLC4A7 (Bagci et al. 2020)<br>SLK (Yamada et al. 2000)<br>WASF1 (Miki et al. 1998) – component of the WAVE1 complex<br>WWP2 (Bagci et al. 2020)
